ArticleFrontiers in oncology2022

Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.

Lifeng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.